Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HDAC1 | Q13547 | 4/20 | 0.61 |
| ▸ | HDAC6 | Q9UBN7 | 4/20 | 0.61 |
| ▸ | HDAC8 | Q9BY41 | 3/20 | 0.61 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.61 |
| ▸ | HDAC4 | P56524 | 2/20 | 0.61 |
| ▸ | HDAC7 | Q8WUI4 | 2/20 | 0.61 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.61 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.61 |
| ▸ | HDAC9 | Q9UKV0 | 2/20 | 0.61 |
| ▸ | HDAC5 | Q9UQL6 | 2/20 | 0.61 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.49 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | LMNA | P02545 | 1/20 | 0.49 |
| ▸ | TP53 | P04637 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | CASP1 | P29466 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6990001 | 0.82 | HDAC1 (0.60) | HDAC1HDAC6HDAC8HDAC3HDAC4 | |
| SCHEMBL6811518 | 0.81 | HDAC1 (0.59) | HDAC1HDAC6HDAC8HDAC3HDAC4 | |
| SCHEMBL6812251 | 0.80 | HDAC1 (0.53) | HDAC1HDAC6HDAC8HDAC3HDAC4 | |
| SCHEMBL16061662 | 0.80 | ALDH1A1 (0.55) | HDAC1HDAC6HDAC8HDAC3HDAC4 | |
| SCHEMBL30197112 | 0.79 | ALDH1A1 (0.53) | HDAC1HDAC6HDAC8HDAC3HDAC4 | |
| SCHEMBL16558088 | 0.78 | HDAC1 (0.75) | HDAC1HDAC6HDAC8HDAC3HDAC4 | |
| SCHEMBL11583860 | 0.78 | CHRM2 (0.47) | KDM4EALDH1A1HSD17B10MEN1LMNA | |
| SCHEMBL6808175 | 0.77 | MEN1 (0.44) | HDAC1HDAC6HDAC8HDAC3HDAC4 | |
| SCHEMBL142527 | 0.76 | MAPT (0.48) | KDM4EALDH1A1HSD17B10MEN1LMNA | |
| SCHEMBL29100113 | 0.76 | ALDH1A1 (0.62) | KDM4EALDH1A1HSD17B10MEN1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112094480-B | Resin composition, and prepreg and laminated board manufactured by using same | 苏州生益科技有限公司 | 2023-04-11 | — | — | CN | disclosed |
| CN-112079763-B | Modified maleimide compound, and prepreg and laminated board manufactured by using same | 苏州生益科技有限公司 | 2022-07-05 | — | — | CN | disclosed |
| CN-112094480-A | Resin composition, and prepreg and laminated board manufactured by using same | 苏州生益科技有限公司 | 2020-12-18 | — | — | CN | disclosed |
| CN-112079763-A | Modified maleimide compound, and prepreg and laminated board manufactured by using same | 苏州生益科技有限公司 | 2020-12-15 | — | — | CN | disclosed |
| CN-112062914-A | Resin composition, and prepreg and laminated board manufactured by using same | 常熟生益科技有限公司 | 2020-12-11 | — | — | CN | disclosed |
| EP-0864592-B1 | DIENE RUBBER | ZEON CORP (JP) | 2004-09-22 | — | — | EP | disclosed |
| US-20040122001-A1 | Pharmaceutical compounds | ELI LILLY AND COMPANY | 2004-06-24 | — | — | US | disclosed |
| EP-1345930-A2 | PHARMACEUTICAL COMPOUNDS | ELI LILLY AND COMPANY (US) | 2003-09-24 | — | — | EP | disclosed |
| WO-2002050067-A2 | PHARMACEUTICAL HETEROCYCLIC COMPOUNDS | ELI LILLY AND COMPANY (US) | 2002-06-27 | — | — | WO | disclosed |
| US-6211321-B1 | CONTAINING A TERTIARY AMINO-CONTAINING VINYL MONOMER AND A HALOGEN CONTAINING VONYL MONOMER | NIPPON ZEON CO., LTD. (JP) | 2001-04-03 | — | — | US | disclosed |
| EP-0864592-A1 | DIENE RUBBER | NIPPON ZEON CO., LTD. (JP) | 1998-09-16 | — | — | EP | disclosed |
| US-5138001-A | Optical disc substrates; low birefringence, heat and moisture absorption resistance, high transparency | TOKUYAMA SODA KABUSHIKI KAISHA (JP) | 1992-08-11 | — | — | US | disclosed |
| US-4205134-A | Carrier for liquid chromatography | TOYO SODA MANUFACTURING COMPANY, LTD. (JP) | 1980-05-27 | — | — | US | disclosed |
| US-4128706-A | Carrier for liquid chromatography | TOYO SODA MANUFACTURING CO., LTD. (JP) | 1978-12-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040122001-A1 | Pharmaceutical compounds | CYP2D6, LPXN, CYP1B1 | HDAC1 3173/4885HDAC6 3196/4885HDAC8 3080/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.